Author: Rita Garwood

Rosenthal & Rosenthal’s Acquisition of Accord Equipment Finance: Expanding Financial Solutions for Growth

Rosenthal & Rosenthal recently acquired the U.S. assets of Accord Equipment Finance. In a conversation with ABF Journal, Paul Schuldiner and Mike Wells of Rosenthal & Rosenthal, delve into the motivations behind the acquisition, the integration of teams and the strategic role equipment finance will play in the company’s future growth.

Blue Owl Agents $2.65B Financing to Support Spaceship Group’s Acquisition of Squarespace

Spaceship Group secured $2.65 billion in financing from Blue Owl Capital to support its acquisition of Squarespace. The package included a $2.1 billion term loan, a $300 million delayed draw term loan, and a $250 million revolving loan.

Goldman Sachs Expands Kennedy Lewis Capital Credit Facility to $500MM

Kennedy Lewis Capital expanded its secured credit facility from $300 million to $500 million, with Goldman Sachs as syndication agent and GS ASL LLC as administrative agent.

Adam Duso: A Disruptor in the World of Asset-Based Lending and Corporate Restructuring

Adam Duso: A Disruptor in the World of Asset-Based Lending and Corporate Restructuring. Adam Duso is reshaping the future of corporate restructuring, turning once bleak financial situations into opportunities for businesses on the brink. As the CEO of Second Wind Consultants, Duso has become a disruptive force, introducing innovative approaches and new options for struggling businesses. His work in transforming how companies navigate distress, particularly through the groundbreaking use of pre-packaged Article 9 restructurings, has driven progress and created opportunities in the industry.

More than a Dealmaker: Tom Siska Drives Innovation and Mentors the Next Generation

More than a Dealmaker: Tom Siska Drives Innovation and Mentors the Next Generation. In the world of specialty finance, where progress meets tradition and every deal can be a game-changer, few leaders have navigated the terrain as effectively as Tom Siska. For over three decades, Siska has been at the forefront of the industry, not just surviving its shifts and challenges but shaping them.

Navigating Uncertainty: The Financial And Ethical Challenges In Biotech Restructuring

Biotechnology, once a hot market for investment, is now facing financial and regulatory challenges. Participants of a Turnaround Management Association panel share insights on the unique financing agreements, regulatory hurdles and ethical considerations that lenders and advisors must consider when working in this space.